These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8743605)

  • 1. Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats.
    Liu WF
    Pharmacol Biochem Behav; 1996 Jun; 54(2):425-30. PubMed ID: 8743605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman.
    Shih TM; Capacio BR; Cook LA
    Pharmacol Biochem Behav; 1993 Mar; 44(3):615-22. PubMed ID: 8095723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats.
    Liu WF
    Neurotoxicol Teratol; 2000; 22(3):389-96. PubMed ID: 10840182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
    Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
    Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various drugs including organophosphorus compounds (OPC) and therapeutic compounds against OPC on DRL responding.
    Bizot JC
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1069-80. PubMed ID: 9586869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    Klockgether T; Wüllner U; Steinbach JP; Petersen V; Turski L; Löschmann PA
    Eur J Pharmacol; 1996 Apr; 301(1-3):67-73. PubMed ID: 8773448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.
    Kimura Y; Ohue M; Kitaura T; Kihira K
    Brain Res; 1999 Jul; 834(1-2):6-12. PubMed ID: 10407088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of oral low doses of pyridostigmine on simple visual discrimination and unconditioned consummatory acts in rats.
    Liu WF
    Pharmacol Biochem Behav; 1992 Jan; 41(1):251-4. PubMed ID: 1539077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinolytic antagonism to the disruptive effects of oral low doses of pyridostigmine on simple discrimination performance in rats.
    Liu WF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):745-9. PubMed ID: 1816561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
    Suitsu N
    Seishin Shinkeigaku Zasshi; 1992; 94(3):238-62. PubMed ID: 1589555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the scopolamine stimulus in rats.
    Jung M; Perio A; Worms P; Biziere K
    Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of nucleus accumbens M(2) muscarinic receptors disrupts operant responding for sucrose under a progressive ratio reinforcement schedule.
    Cousens GA; Beckley JT
    Behav Brain Res; 2007 Jul; 181(1):127-35. PubMed ID: 17499370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eseroline on schedule-controlled behavior in the rat.
    Liu WF
    Pharmacol Biochem Behav; 1991 Apr; 38(4):747-51. PubMed ID: 1871191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine.
    Bensadoun JC; Brooks SP; Dunnett SB
    Psychopharmacology (Berl); 2004 Jul; 174(3):396-405. PubMed ID: 14985934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-nicotinic properties of anticholinergic antiparkinson drugs.
    Gao ZG; Liu BY; Cui WY; Li LJ; Fan QH; Liu CG
    J Pharm Pharmacol; 1998 Nov; 50(11):1299-305. PubMed ID: 9877318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers.
    Guthrie SK; Manzey L; Scott D; Giordani B; Tandon R
    J Clin Psychopharmacol; 2000 Feb; 20(1):77-83. PubMed ID: 10653212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
    Prus AJ; Baker LE; Meltzer HY
    Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of rewarding and reinforcing properties of biperiden in conditioned place preference in rats.
    Allahverdiyev O; Nurten A; Enginar N
    Behav Brain Res; 2011 Dec; 225(2):642-5. PubMed ID: 21855580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats.
    van Haaren F; Haworth SC; Bennett SM; Cody BA; Hoy JB; Karlix JL; Tebbett IR
    Pharmacol Biochem Behav; 2001; 69(1-2):23-33. PubMed ID: 11420065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.